La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease.

Identifieur interne : 001F44 ( Ncbi/Curation ); précédent : 001F43; suivant : 001F45

Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease.

Auteurs : M. Merad-Boudia [France] ; A. Nicole ; D. Santiard-Baron ; C. Saillé ; I. Ceballos-Picot

Source :

RBID : pubmed:9783733

English descriptors

Abstract

In Parkinson's disease (PD), dopaminergic cell death in the substantia nigra was associated with a profound glutathione (GSH) decrease and a mitochondrial dysfunction. The fall in GSH concentration seemed to appear before the mitochondrial impairment and the cellular death, suggesting that a link may exist between these events. The relationships between GSH depletion, reactive oxygen species (ROS) production, mitochondrial dysfunction and the mode of cell death in neuronal cells remain to be resolved and will provide important insights into the etiology of Parkinson's disease. An approach to determine the role of GSH in the mitochondrial function and in neurodegeneration was to create a selective depletion of GSH in a neuronal cell line in culture (NS20Y) by inhibiting its biosynthesis with L-buthionine-(S,R)-sulfoximine (BSO), a specific inhibitor of gamma-glutamylcysteine synthetase. This treatment led to a nearly complete GSH depletion after 24 hr and induced cellular death via an apoptotic pathway after 5 days of BSO treatment. By using the reactive oxygen species-sensitive probe 2',7'-dichlorofluorescin, we observed that the rapid GSH depletion was accompanied, early in the process, by a strong and transient intracellular increase in reactive oxygen species evidenced after 1 hr with BSO, culminating after 3 hr when the GSH level decreased to 30% of normal. GSH depletion induced a loss of mitochondrial function after 48 hr of BSO treatment. In particular, the activities of complexes I, II and IV of the respiratory chain were decreased by 32, 70 and 65%, respectively as compared to controls. These results showed the crucial role of GSH for maintaining the integrity of mitochondrial function in neuronal cells. Oxidative stress and mitochondrial impairment, preceding DNA fragmentation, could be early events in the apoptotic process induced by GSH depletion. Our data are consistent with the hypothesis that GSH depletion could contribute to neuronal apoptosis in Parkinson's disease through oxidative stress and mitochondrial dysfunction.

PubMed: 9783733

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:9783733

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease.</title>
<author>
<name sortKey="Merad Boudia, M" sort="Merad Boudia, M" uniqKey="Merad Boudia M" first="M" last="Merad-Boudia">M. Merad-Boudia</name>
<affiliation wicri:level="3">
<nlm:affiliation>CNRS URA 1335, CHU Necker-Enfants Malades, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CNRS URA 1335, CHU Necker-Enfants Malades, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nicole, A" sort="Nicole, A" uniqKey="Nicole A" first="A" last="Nicole">A. Nicole</name>
</author>
<author>
<name sortKey="Santiard Baron, D" sort="Santiard Baron, D" uniqKey="Santiard Baron D" first="D" last="Santiard-Baron">D. Santiard-Baron</name>
</author>
<author>
<name sortKey="Saille, C" sort="Saille, C" uniqKey="Saille C" first="C" last="Saillé">C. Saillé</name>
</author>
<author>
<name sortKey="Ceballos Picot, I" sort="Ceballos Picot, I" uniqKey="Ceballos Picot I" first="I" last="Ceballos-Picot">I. Ceballos-Picot</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1998">1998</date>
<idno type="RBID">pubmed:9783733</idno>
<idno type="pmid">9783733</idno>
<idno type="wicri:Area/PubMed/Corpus">001460</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001460</idno>
<idno type="wicri:Area/PubMed/Curation">001419</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001419</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001419</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001419</idno>
<idno type="wicri:Area/Ncbi/Merge">001F44</idno>
<idno type="wicri:Area/Ncbi/Curation">001F44</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease.</title>
<author>
<name sortKey="Merad Boudia, M" sort="Merad Boudia, M" uniqKey="Merad Boudia M" first="M" last="Merad-Boudia">M. Merad-Boudia</name>
<affiliation wicri:level="3">
<nlm:affiliation>CNRS URA 1335, CHU Necker-Enfants Malades, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CNRS URA 1335, CHU Necker-Enfants Malades, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nicole, A" sort="Nicole, A" uniqKey="Nicole A" first="A" last="Nicole">A. Nicole</name>
</author>
<author>
<name sortKey="Santiard Baron, D" sort="Santiard Baron, D" uniqKey="Santiard Baron D" first="D" last="Santiard-Baron">D. Santiard-Baron</name>
</author>
<author>
<name sortKey="Saille, C" sort="Saille, C" uniqKey="Saille C" first="C" last="Saillé">C. Saillé</name>
</author>
<author>
<name sortKey="Ceballos Picot, I" sort="Ceballos Picot, I" uniqKey="Ceballos Picot I" first="I" last="Ceballos-Picot">I. Ceballos-Picot</name>
</author>
</analytic>
<series>
<title level="j">Biochemical pharmacology</title>
<idno type="ISSN">0006-2952</idno>
<imprint>
<date when="1998" type="published">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Apoptosis (physiology)</term>
<term>Buthionine Sulfoximine (pharmacology)</term>
<term>Cell Line</term>
<term>Electron Transport (physiology)</term>
<term>Enzyme Inhibitors (pharmacology)</term>
<term>Glutamate-Cysteine Ligase (antagonists & inhibitors)</term>
<term>Glutathione (metabolism)</term>
<term>Mice</term>
<term>Mitochondria (physiology)</term>
<term>Neurons (metabolism)</term>
<term>Neurons (pathology)</term>
<term>Oxidation-Reduction</term>
<term>Oxidative Stress (physiology)</term>
<term>Parkinson Disease (metabolism)</term>
<term>Parkinson Disease (pathology)</term>
<term>Time Factors</term>
<term>Tumor Cells, Cultured</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Glutamate-Cysteine Ligase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Glutathione</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Buthionine Sulfoximine</term>
<term>Enzyme Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Neurons</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Neurons</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Apoptosis</term>
<term>Electron Transport</term>
<term>Mitochondria</term>
<term>Oxidative Stress</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cell Line</term>
<term>Mice</term>
<term>Oxidation-Reduction</term>
<term>Time Factors</term>
<term>Tumor Cells, Cultured</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In Parkinson's disease (PD), dopaminergic cell death in the substantia nigra was associated with a profound glutathione (GSH) decrease and a mitochondrial dysfunction. The fall in GSH concentration seemed to appear before the mitochondrial impairment and the cellular death, suggesting that a link may exist between these events. The relationships between GSH depletion, reactive oxygen species (ROS) production, mitochondrial dysfunction and the mode of cell death in neuronal cells remain to be resolved and will provide important insights into the etiology of Parkinson's disease. An approach to determine the role of GSH in the mitochondrial function and in neurodegeneration was to create a selective depletion of GSH in a neuronal cell line in culture (NS20Y) by inhibiting its biosynthesis with L-buthionine-(S,R)-sulfoximine (BSO), a specific inhibitor of gamma-glutamylcysteine synthetase. This treatment led to a nearly complete GSH depletion after 24 hr and induced cellular death via an apoptotic pathway after 5 days of BSO treatment. By using the reactive oxygen species-sensitive probe 2',7'-dichlorofluorescin, we observed that the rapid GSH depletion was accompanied, early in the process, by a strong and transient intracellular increase in reactive oxygen species evidenced after 1 hr with BSO, culminating after 3 hr when the GSH level decreased to 30% of normal. GSH depletion induced a loss of mitochondrial function after 48 hr of BSO treatment. In particular, the activities of complexes I, II and IV of the respiratory chain were decreased by 32, 70 and 65%, respectively as compared to controls. These results showed the crucial role of GSH for maintaining the integrity of mitochondrial function in neuronal cells. Oxidative stress and mitochondrial impairment, preceding DNA fragmentation, could be early events in the apoptotic process induced by GSH depletion. Our data are consistent with the hypothesis that GSH depletion could contribute to neuronal apoptosis in Parkinson's disease through oxidative stress and mitochondrial dysfunction.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F44 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001F44 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:9783733
   |texte=   Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:9783733" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024